{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T03:43:05Z","timestamp":1761709385728},"reference-count":85,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2017,10,6]],"date-time":"2017-10-06T00:00:00Z","timestamp":1507248000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Internist"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1007\/s00108-017-0334-9","type":"journal-article","created":{"date-parts":[[2017,10,6]],"date-time":"2017-10-06T09:07:41Z","timestamp":1507280861000},"page":"1150-1162","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Aspergillus-Nachweis im Atemwegsmaterial"],"prefix":"10.1007","volume":"58","author":[{"given":"H. J. F.","family":"Salzer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Lange","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"H\u00f6nigl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,10,6]]},"reference":[{"issue":"2","key":"334_CR1","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1183\/13993003.01062-2016","volume":"49","author":"D Lowes","year":"2017","unstructured":"Lowes D, Al-Shair K, Newton PJ, Morris J, Harris C, Rautemaa-Richardson R et al (2017) Predictors of mortality in chronic pulmonary aspergillosis. Eur Respir\u00a0J 8;49(2)","journal-title":"Eur Respir J"},{"key":"334_CR2","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02520-2016","author":"HJ Salzer","year":"2017","unstructured":"Salzer HJ, Cornely OA (2017) Awareness of predictors of mortality may help improve outcome in chronic pulmonary aspergillosis. Eur Respir\u00a0J. \n                        https:\/\/doi.org\/10.1183\/13993003.02520-2016","journal-title":"Eur Respir J"},{"issue":"1","key":"334_CR3","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1183\/13993003.00583-2015","volume":"47","author":"DW Denning","year":"2016","unstructured":"Denning DW, Cadranel J, Beigelman-Aubry C, Ader F, Chakrabarti A, Blot S et al (2016) Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management. Eur Respir\u00a0J 47(1):45\u201368","journal-title":"Eur Respir J"},{"issue":"2","key":"334_CR4","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/myc.12589","volume":"60","author":"HJ Salzer","year":"2017","unstructured":"Salzer HJ, Heyckendorf J, Kalsdorf B, Rolling T, Lange C (2017) Characterization of patients with chronic pulmonary aspergillosis according to the new ESCMID\/ERS\/ECMM and IDSA guidelines. Mycoses 60(2):136\u2013142","journal-title":"Mycoses"},{"issue":"1","key":"334_CR5","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/crj.12105","volume":"9","author":"B Camara","year":"2015","unstructured":"Camara B, Reymond E, Saint-Raymond C, Roth H, Brenier-Pinchart MP, Pinel C et al (2015) Characteristics and outcomes of chronic pulmonary aspergillosis: a\u00a0retrospective analysis of a\u00a0tertiary hospital registry. Clin Respir\u00a0J 9(1):65\u201373","journal-title":"Clin Respir J"},{"issue":"5","key":"334_CR6","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.rmed.2012.01.014","volume":"106","author":"H Ohba","year":"2012","unstructured":"Ohba H, Miwa S, Shirai M, Kanai M, Eifuku T, Suda T et\u00a0al (2012) Clinical characteristics and prognosis of chronic pulmonary aspergillosis. Respir Med 106(5):724\u2013729","journal-title":"Respir Med"},{"issue":"11","key":"334_CR7","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.jiac.2015.08.006","volume":"21","author":"K Koyama","year":"2015","unstructured":"Koyama K, Ohshima N, Suzuki J, Kawashima M, Okuda K, Sato R et\u00a0al (2015) Evaluation of clinical characteristics and prognosis of chronic pulmonary aspergillosis depending on the underlying lung diseases: emphysema vs prior tuberculosis. J\u00a0Infect Chemother 21(11):795\u2013801","journal-title":"J Infect Chemother"},{"issue":"12","key":"334_CR8","doi-asserted-by":"crossref","first-page":"864","DOI":"10.2471\/BLT.11.089441","volume":"89","author":"DW Denning","year":"2011","unstructured":"Denning DW, Pleuvry A, Cole DC (2011) Global burden of chronic pulmonary aspergillosis as a\u00a0sequel to pulmonary tuberculosis. Bull World Health Organ 89(12):864\u2013872","journal-title":"Bull World Health Organ"},{"issue":"9","key":"334_CR9","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1007\/s10096-015-2409-7","volume":"34","author":"MT Hedayati","year":"2015","unstructured":"Hedayati MT, Azimi Y, Droudinia A, Mousavi B, Khalilian A, Hedayati N et\u00a0al (2015) Prevalence of chronic pulmonary aspergillosis in patients with tuberculosis from Iran. Eur J Clin Microbiol Infect Dis 34(9):1759\u20131765","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"2","key":"334_CR10","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.jinf.2015.11.003","volume":"72","author":"ID Page","year":"2016","unstructured":"Page ID, Richardson MD, Denning DW (2016) Comparison of six aspergillus-specific IgG assays for the diagnosis of chronic pulmonary aspergillosis (CPA). J\u00a0Infect 72(2):240\u2013249","journal-title":"J Infect"},{"issue":"4","key":"334_CR11","doi-asserted-by":"crossref","first-page":"E197","DOI":"10.1111\/1469-0691.12133","volume":"19","author":"CG Baxter","year":"2013","unstructured":"Baxter CG, Denning DW, Jones AM, Todd A, Moore CB, Richardson MD (2013) Performance of two Aspergillus IgG EIA assays compared with the precipitin test in chronic and allergic aspergillosis. Clin Microbiol Infect 19(4):E197\u2013E204","journal-title":"Clin Microbiol Infect"},{"issue":"4","key":"334_CR12","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/ciw326","volume":"63","author":"TF Patterson","year":"2016","unstructured":"Patterson TF, Thompson GR 3rd, Denning DW, Fishman JA, Hadley S, Herbrecht R et\u00a0al (2016) Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis 63(4):e1\u2013e60","journal-title":"Clin Infect Dis"},{"issue":"Suppl 3","key":"334_CR13","doi-asserted-by":"crossref","first-page":"S265","DOI":"10.1086\/376526","volume":"37","author":"DW Denning","year":"2003","unstructured":"Denning DW, Riniotis K, Dobrashian R, Sambatakou H (2003) Chronic cavitary and fibrosing pulmonary and pleural aspergillosis: case series, proposed nomenclature change, and review. Clin Infect Dis 37(Suppl 3):S265\u2013S280","journal-title":"Clin Infect Dis"},{"issue":"5","key":"334_CR14","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1093\/mmy\/myv020","volume":"53","author":"ID Page","year":"2015","unstructured":"Page ID, Richardson M, Denning DW (2015) Antibody testing in aspergillosis\u2014quo vadis? Med Mycol 53(5):417\u2013439","journal-title":"Med Mycol"},{"issue":"8","key":"334_CR15","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s10096-003-0970-y","volume":"22","author":"ML Uffredi","year":"2003","unstructured":"Uffredi ML, Mangiapan G, Cadranel J, Kac G (2003) Significance of aspergillus fumigatus isolation from respiratory specimens of nongranulocytopenic patients. Eur J Clin Microbiol Infect Dis 22(8):457\u2013462","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"3","key":"334_CR16","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.diagmicrobio.2012.07.002","volume":"74","author":"AW Toorenenbergen van","year":"2012","unstructured":"van Toorenenbergen AW (2012) Between-laboratory quality control of automated analysis of IgG antibodies against aspergillus fumigatus. Diagn Microbiol Infect Dis 74(3):278\u2013281","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"5","key":"334_CR17","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1378\/chest.06-2441","volume":"131","author":"J Camuset","year":"2007","unstructured":"Camuset J, Nunes H, Dombret MC, Bergeron A, Henno P, Philippe B et\u00a0al (2007) Treatment of chronic pulmonary aspergillosis by voriconazole in nonimmunocompromised patients. Chest 131(5):1435\u20131441","journal-title":"Chest"},{"issue":"6","key":"334_CR18","doi-asserted-by":"crossref","first-page":"e479","DOI":"10.1016\/j.ijid.2009.07.011","volume":"14","author":"HS Nam","year":"2010","unstructured":"Nam HS, Jeon K, Um SW, Suh GY, Chung MP, Kim H et\u00a0al (2010) Clinical characteristics and treatment outcomes of chronic necrotizing pulmonary aspergillosis: a\u00a0review of 43 cases. Int J Infect Dis 14(6):e479\u2013e482","journal-title":"Int J Infect Dis"},{"issue":"5","key":"334_CR19","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/myc.12075","volume":"56","author":"R Agarwal","year":"2013","unstructured":"Agarwal R, Vishwanath G, Aggarwal AN, Garg M, Gupta D, Chakrabarti A (2013) Itraconazole in chronic cavitary pulmonary aspergillosis: a\u00a0randomised controlled trial and systematic review of literature. Mycoses 56(5):559\u2013570","journal-title":"Mycoses"},{"issue":"11","key":"334_CR20","doi-asserted-by":"crossref","first-page":"3231","DOI":"10.1007\/s10096-012-1690-y","volume":"31","author":"J Cadranel","year":"2012","unstructured":"Cadranel J, Philippe B, Hennequin C, Bergeron A, Bergot E, Bourdin A et\u00a0al (2012) Voriconazole for chronic pulmonary aspergillosis: a\u00a0prospective multicenter trial. Eur J Clin Microbiol Infect Dis 31(11):3231\u20133239","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"6","key":"334_CR21","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1055\/s-0031-1295716","volume":"32","author":"C Hogan","year":"2011","unstructured":"Hogan C, Denning DW (2011) Allergic bronchopulmonary aspergillosis and related allergic syndromes. Semin Respir Crit Care Med 32(6):682\u2013692","journal-title":"Semin Respir Crit Care Med"},{"issue":"12","key":"334_CR22","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1086\/657306","volume":"51","author":"TW Felton","year":"2010","unstructured":"Felton TW, Baxter C, Moore CB, Roberts SA, Hope WW, Denning DW (2010) Efficacy and safety of posaconazole for chronic pulmonary aspergillosis. Clin Infect Dis 51(12):1383\u20131391","journal-title":"Clin Infect Dis"},{"issue":"2","key":"334_CR23","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0002-9343(97)89455-7","volume":"100","author":"JA Horvath","year":"1996","unstructured":"Horvath JA, Dummer S (1996) The use of respiratory-tract cultures in the diagnosis of invasive pulmonary aspergillosis. Am J Med 100(2):171\u2013178","journal-title":"Am J Med"},{"issue":"8","key":"334_CR24","doi-asserted-by":"crossref","first-page":"659","DOI":"10.2165\/00023210-200721080-00004","volume":"21","author":"M Ruhnke","year":"2007","unstructured":"Ruhnke M, Kofla G, Otto K, Schwartz S (2007) CNS aspergillosis: recognition, diagnosis and management. CNS Drugs 21(8):659\u2013676","journal-title":"CNS Drugs"},{"issue":"8","key":"334_CR25","doi-asserted-by":"crossref","first-page":"811","DOI":"10.3109\/13693786.2012.682228","volume":"50","author":"K Izumikawa","year":"2012","unstructured":"Izumikawa K, Yamamoto Y, Mihara T, Takazono T, Morinaga Y, Kurihara S et\u00a0al (2012) Bronchoalveolar lavage galactomannan for the diagnosis of chronic pulmonary aspergillosis. Med Mycol 50(8):811\u2013817","journal-title":"Med Mycol"},{"issue":"5","key":"334_CR26","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.jinf.2014.01.005","volume":"68","author":"B Shin","year":"2014","unstructured":"Shin B, Koh WJ, Jeong BH, Yoo H, Park HY, Suh GY et\u00a0al (2014) Serum galactomannan antigen test for the diagnosis of chronic pulmonary aspergillosis. J\u00a0Infect 68(5):494\u2013499","journal-title":"J Infect"},{"issue":"6","key":"334_CR27","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1128\/JCM.02497-16","volume":"55","author":"N Urabe","year":"2017","unstructured":"Urabe N, Sakamoto S, Sano G, Suzuki J, Hebisawa A, Nakamura Y et al (2017) Usefulness of two aspergillus PCR assays and aspergillus galactomannan and beta-d-glucan testing of bronchoalveolar lavage fluid for diagnosis of chronic pulmonary aspergillosis. J\u00a0Clin Microbiol 55(6):1738\u20131746","journal-title":"J Clin Microbiol"},{"issue":"11","key":"334_CR28","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.2217\/fmb.11.118","volume":"6","author":"DW Denning","year":"2011","unstructured":"Denning DW, Perlin DS (2011) Azole resistance in aspergillus: a\u00a0growing public health menace. Future Microbiol 6(11):1229\u20131232","journal-title":"Future Microbiol"},{"issue":"5","key":"334_CR29","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1086\/322606","volume":"33","author":"MM McNeil","year":"2001","unstructured":"McNeil MM, Nash SL, Hajjeh RA, Phelan MA, Conn LA, Plikaytis BD et\u00a0al (2001) Trends in mortality due to invasive mycotic diseases in the United States, 1980\u20131997. Clin Infect Dis 33(5):641\u2013647","journal-title":"Clin Infect Dis"},{"issue":"9490","key":"334_CR30","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/S0140-6736(05)67381-3","volume":"366","author":"TF Patterson","year":"2005","unstructured":"Patterson TF (2005) Advances and challenges in management of invasive mycoses. Lancet 366(9490):1013\u20131025","journal-title":"Lancet"},{"issue":"7","key":"334_CR31","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/myc.12628","volume":"60","author":"OA Cornely","year":"2017","unstructured":"Cornely OA, Lass-Florl C, Lagrou K, Arsic-Arsenijevic V, Hoenigl M (2017) Improving outcome of fungal diseases \u2013 guiding experts and patients towards excellence. Mycoses 60(7):420\u2013425","journal-title":"Mycoses"},{"issue":"6","key":"334_CR32","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.ijantimicag.2012.02.002","volume":"39","author":"M Hoenigl","year":"2012","unstructured":"Hoenigl M, Raggam RB, Salzer HJ, Valentin T, Valentin A, Zollner-Schwetz I et al (2012) Posaconazole plasma concentrations and invasive mould infections in patients with haematological malignancies. Int J Antimicrob Agents 39(6):510\u2013513","journal-title":"Int J Antimicrob Agents"},{"issue":"8","key":"334_CR33","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1097\/TP.0000000000000153","volume":"98","author":"B Willinger","year":"2014","unstructured":"Willinger B, Lackner M, Lass-Florl C, Prattes J, Posch V, Selitsch B et al (2014) Bronchoalveolar lavage lateral-flow device test for invasive pulmonary aspergillosis in solid organ transplant patients: a\u00a0semiprospective multicenter study. Transplantation 98(8):898\u2013902","journal-title":"Transplantation"},{"issue":"12","key":"334_CR34","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1111\/j.1469-0691.2011.03548.x","volume":"17","author":"O Lortholary","year":"2011","unstructured":"Lortholary O, Gangneux JP, Sitbon K, Lebeau B, de Monbrison F, Le Strat Y et\u00a0al (2011) Epidemiological trends in invasive aspergillosis in France: the SAIF network (2005\u20132007). Clin Microbiol Infect 17(12):1882\u20131889","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"334_CR35","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1164\/rccm.200704-606OC","volume":"177","author":"W Meersseman","year":"2008","unstructured":"Meersseman W, Lagrou K, Maertens J, Wilmer A, Hermans G, Vanderschueren S et\u00a0al (2008) Galactomannan in bronchoalveolar lavage fluid: a\u00a0tool for diagnosing aspergillosis in intensive care unit patients. Am J Respir Crit Care Med 177(1):27\u201334","journal-title":"Am J Respir Crit Care Med"},{"key":"334_CR36","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1471-2334-13-29","volume":"13","author":"JW Baddley","year":"2013","unstructured":"Baddley JW, Stephens JM, Ji X, Gao X, Schlamm HT, Tarallo M (2013) Aspergillosis in Intensive Care Unit (ICU) patients: epidemiology and economic outcomes. BMC Infect Dis 13:29","journal-title":"BMC Infect Dis"},{"issue":"3","key":"334_CR37","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.jinf.2014.04.010","volume":"69","author":"M Lugosi","year":"2014","unstructured":"Lugosi M, Alberti C, Zahar JR, Garrouste M, Lemiale V, Descorps-Desclere A et al (2014) Aspergillus in the lower respiratory tract of immunocompetent critically ill patients. J\u00a0Infect 69(3):284\u2013292","journal-title":"J Infect"},{"issue":"2","key":"334_CR38","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1097\/QCO.0000000000000043","volume":"27","author":"D Koulenti","year":"2014","unstructured":"Koulenti D, Garnacho-Montero J, Blot S (2014) Approach to invasive pulmonary aspergillosis in critically ill patients. Curr Opin Infect Dis 27(2):174\u2013183","journal-title":"Curr. Opin. Infect. Dis."},{"issue":"5","key":"334_CR39","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1179\/acb.2004.037","volume":"59","author":"K Vandewoude","year":"2004","unstructured":"Vandewoude K, Blot S, Benoit D, Depuydt P, Vogelaers D, Colardyn F (2004) Invasive aspergillosis in critically ill patients: analysis of risk factors for acquisition and mortality. Acta Clin Belg 59(5):251\u2013257","journal-title":"Acta Clin Belg"},{"issue":"11","key":"334_CR40","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1007\/s00134-012-2673-2","volume":"38","author":"J Wauters","year":"2012","unstructured":"Wauters J, Baar I, Meersseman P, Meersseman W, Dams K, De Paep R et\u00a0al (2012) Invasive pulmonary aspergillosis is a\u00a0frequent complication of critically ill H1N1 patients: a\u00a0retrospective study. Intensive Care Med 38(11):1761\u20131768","journal-title":"Intensive Care Med"},{"key":"334_CR41","doi-asserted-by":"publisher","DOI":"10.1093\/mmy\/myx011","author":"J Prattes","year":"2017","unstructured":"Prattes J, Hoenigl M, Krause R, Buzina W, Valentin T, Reischies F et\u00a0al (2017) Invasive aspergillosis in patients with underlying liver cirrhosis: a\u00a0prospective cohort study. Med Mycol. \n                        https:\/\/doi.org\/10.1093\/mmy\/myx011","journal-title":"Med Mycol"},{"key":"334_CR42","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1186\/s13054-015-0905-x","volume":"19","author":"S Eigl","year":"2015","unstructured":"Eigl S, Prattes J, Lackner M, Willinger B, Spiess B, Reinwald M et al (2015) Multicenter evaluation of a\u00a0lateral-flow device test for diagnosing invasive pulmonary aspergillosis in ICU patients. Crit Care 19:178","journal-title":"Crit Care"},{"issue":"8","key":"334_CR43","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1164\/rccm.201407-1275OC","volume":"190","author":"J Prattes","year":"2014","unstructured":"Prattes J, Flick H, Pruller F, Koidl C, Raggam RB, Palfner M et\u00a0al (2014) Novel tests for diagnosis of invasive aspergillosis in patients with underlying respiratory diseases. Am J Respir Crit Care Med 190(8):922\u2013929","journal-title":"Am J Respir Crit Care Med"},{"issue":"7","key":"334_CR44","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1111\/j.1469-0691.2009.03015.x","volume":"16","author":"J Guinea","year":"2010","unstructured":"Guinea J, Torres-Narbona M, Gijon P, Munoz P, Pozo F, Pelaez T et al (2010) Pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: incidence, risk factors, and outcome. Clin Microbiol Infect 16(7):870\u2013877","journal-title":"Clin Microbiol Infect"},{"key":"334_CR45","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13054-014-0722-7","volume":"19","author":"FS Taccone","year":"2015","unstructured":"Taccone FS, Van den Abeele AM, Bulpa P, Misset B, Meersseman W, Cardoso T et\u00a0al (2015) Epidemiology of invasive aspergillosis in critically ill patients: clinical presentation, underlying conditions, and outcomes. Crit Care 19:7","journal-title":"Crit Care"},{"issue":"1","key":"334_CR46","doi-asserted-by":"publisher","first-page":"87.e1","DOI":"10.1016\/j.cmi.2014.08.011","volume":"21","author":"L Klingspor","year":"2015","unstructured":"Klingspor L, Tortorano AM, Peman J, Willinger B, Hamal P, Sendid B et\u00a0al (2015) Invasive Candida infections in surgical patients in intensive care units: a\u00a0prospective, multicentre survey initiated by the European Confederation of Medical Mycology (ECMM) (2006\u20132008). Clin Microbiol Infect 21(1):87.e1\u201387.e10. \n                        https:\/\/doi.org\/10.1016\/j.cmi.2014.08.011","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"334_CR47","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1439-0507.2011.02044.x","volume":"55","author":"AM Tortorano","year":"2012","unstructured":"Tortorano AM, Dho G, Prigitano A, Breda G, Grancini A, Emmi V et\u00a0al (2012) Invasive fungal infections in the intensive care unit: a\u00a0multicentre, prospective, observational study in Italy (2006\u20132008). Mycoses 55(1):73\u201379","journal-title":"Mycoses"},{"issue":"6","key":"334_CR48","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1164\/rccm.200401-093OC","volume":"170","author":"W Meersseman","year":"2004","unstructured":"Meersseman W, Vandecasteele SJ, Wilmer A, Verbeken E, Peetermans WE, Van Wijngaerden E (2004) Invasive aspergillosis in critically ill patients without malignancy. Am J Respir Crit Care Med 170(6):621\u2013625","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"334_CR49","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1086\/518852","volume":"45","author":"W Meersseman","year":"2007","unstructured":"Meersseman W, Lagrou K, Maertens J, Van Wijngaerden E (2007) Invasive aspergillosis in the intensive care unit. Clin Infect Dis 45(2):205\u2013216","journal-title":"Clin Infect Dis"},{"issue":"7","key":"334_CR50","doi-asserted-by":"crossref","first-page":"3262","DOI":"10.1128\/AAC.00251-13","volume":"57","author":"M Hoenigl","year":"2013","unstructured":"Hoenigl M, Duettmann W, Raggam RB, Seeber K, Troppan K, Fruhwald S et\u00a0al (2013) Potential factors for inadequate voriconazole plasma concentrations in intensive care unit patients and patients with hematological malignancies. Antimicrob Agents Chemother 57(7):3262\u20133267","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl 2","key":"334_CR51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/myc.12224","volume":"57","author":"F Reischies","year":"2014","unstructured":"Reischies F, Hoenigl M (2014) The role of surgical debridement in different clinical manifestations of invasive aspergillosis. Mycoses 57(Suppl 2):1\u201314","journal-title":"Mycoses"},{"issue":"12","key":"334_CR52","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1086\/588660","volume":"46","author":"B Pauw De","year":"2008","unstructured":"De Pauw B, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, Calandra T et\u00a0al (2008) Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer\/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC\/MSG) Consensus Group. Clin Infect Dis 46(12):1813\u20131821","journal-title":"Clin Infect Dis"},{"issue":"4","key":"334_CR53","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1183\/09031936.00062206","volume":"30","author":"P Bulpa","year":"2007","unstructured":"Bulpa P, Dive A, Sibille Y (2007) Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease. Eur Respir\u00a0J 30(4):782\u2013800","journal-title":"Eur Respir J"},{"issue":"1","key":"334_CR54","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1164\/rccm.201111-1978OC","volume":"186","author":"SI Blot","year":"2012","unstructured":"Blot SI, Taccone FS, Van den Abeele AM, Bulpa P, Meersseman W, Brusselaers N et\u00a0al (2012) A clinical algorithm to diagnose invasive pulmonary aspergillosis in critically ill patients. Am J Respir Crit Care Med 186(1):56\u201364","journal-title":"Am J Respir Crit Care Med"},{"issue":"8","key":"334_CR55","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1093\/jac\/dks155","volume":"67","author":"M Hoenigl","year":"2012","unstructured":"Hoenigl M, Strenger V, Buzina W, Valentin T, Koidl C, Wolfler A et\u00a0al (2012) European Organization for the Research and Treatment of Cancer\/Mycoses Study Group (EORTC\/MSG) host factors and invasive fungal infections in patients with haematological malignancies. J\u00a0Antimicrob Chemother 67(8):2029\u20132033","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"334_CR56","doi-asserted-by":"crossref","first-page":"R31","DOI":"10.1186\/cc4823","volume":"10","author":"KH Vandewoude","year":"2006","unstructured":"Vandewoude KH, Blot SI, Depuydt P, Benoit D, Temmerman W, Colardyn F et\u00a0al (2006) Clinical relevance of aspergillus isolation from respiratory tract samples in critically ill patients. Crit Care 10(1):R31","journal-title":"Crit Care"},{"key":"334_CR57","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1186\/1471-2334-12-295","volume":"12","author":"J Barberan","year":"2012","unstructured":"Barberan J, Alcazar B, Malmierca E, Garcia de la Llana F, Dorca J, Del Castillo D et al (2012) Repeated aspergillus isolation in respiratory samples from non-immunocompromised patients not selected based on clinical diagnoses: colonisation or infection? Bmc Infect Dis 12:295","journal-title":"Bmc Infect Dis"},{"issue":"1","key":"334_CR58","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/2049-6958-8-59","volume":"8","author":"N Tutar","year":"2013","unstructured":"Tutar N, Metan G, Koc AN, Yilmaz I, Bozkurt I, Simsek ZO et\u00a0al (2013) Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease. Multidiscip Respir Med 8(1):59","journal-title":"Multidiscip Respir Med"},{"key":"334_CR59","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1186\/s13054-015-1140-1","volume":"19","author":"C Delsuc","year":"2015","unstructured":"Delsuc C, Cottereau A, Frealle E, Bienvenu AL, Dessein R, Jarraud S et\u00a0al (2015) Putative invasive pulmonary aspergillosis in critically ill patients with chronic obstructive pulmonary disease: a\u00a0matched cohort study. Crit Care 19:421","journal-title":"Crit Care"},{"issue":"4","key":"334_CR60","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.ijantimicag.2015.05.017","volume":"46","author":"S Eigl","year":"2015","unstructured":"Eigl S, Prattes J, Reinwald M, Thornton CR, Reischies F, Spiess B et al (2015) Influence of mould-active antifungal treatment on the performance of the aspergillus-specific bronchoalveolar lavage fluid lateral-flow device test. Int J Antimicrob Agents 46(4):401\u2013405","journal-title":"Int J Antimicrob Agents"},{"issue":"5","key":"334_CR61","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1093\/mmy\/myw102","volume":"55","author":"S Eigl","year":"2016","unstructured":"Eigl S, Hoenigl M, Spiess B, Heldt S, Prattes J, Neumeister P et al (2016) Galactomannan testing and aspergillus PCR in same-day bronchoalveolar lavage and blood samples for diagnosis of invasive aspergillosis. Med Mycol 55(5):528. \n                        https:\/\/doi.org\/10.1093\/mmy\/myw102","journal-title":"Med Mycol"},{"issue":"6","key":"334_CR62","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.jinf.2016.02.019","volume":"72","author":"J Fortun","year":"2016","unstructured":"Fortun J, Martin-Davila P, Gomez Garcia de la Pedrosa E, Silva JT, Garcia-Rodriguez J, Benito D et al (2016) Galactomannan in bronchoalveolar lavage fluid for diagnosis of invasive aspergillosis in non-hematological patients. J\u00a0Infect 72(6):738\u2013744","journal-title":"J Infect"},{"issue":"6","key":"334_CR63","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1128\/JCM.00467-14","volume":"52","author":"M Hoenigl","year":"2014","unstructured":"Hoenigl M, Prattes J, Spiess B, Wagner J, Prueller F, Raggam RB et al (2014) Performance of galactomannan, beta-d-glucan, aspergillus lateral-flow device, conventional culture, and PCR tests with bronchoalveolar lavage fluid for diagnosis of invasive pulmonary aspergillosis. J\u00a0Clin Microbiol 52(6):2039\u20132045","journal-title":"J Clin Microbiol"},{"issue":"12","key":"334_CR64","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1111\/myc.12424","volume":"58","author":"T Boch","year":"2015","unstructured":"Boch T, Reinwald M, Postina P, Cornely OA, Vehreschild JJ, Heussel CP et al (2015) Identification of invasive fungal diseases in immunocompromised patients by combining an aspergillus specific PCR with a\u00a0multifungal DNA-microarray from primary clinical samples. Mycoses 58(12):735\u2013745","journal-title":"Mycoses"},{"issue":"7","key":"334_CR65","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1128\/JCM.00110-15","volume":"53","author":"GL Johnson","year":"2015","unstructured":"Johnson GL, Sarker SJ, Nannini F, Ferrini A, Taylor E, Lass-Florl C et al (2015) Aspergillus-specific lateral-flow device and real-time PCR testing of bronchoalveolar lavage fluid: a\u00a0combination biomarker approach for clinical diagnosis of invasive pulmonary aspergillosis. J\u00a0Clin Microbiol 53(7):2103\u20132108","journal-title":"J Clin Microbiol"},{"issue":"7","key":"334_CR66","doi-asserted-by":"crossref","first-page":"e103113","DOI":"10.1371\/journal.pone.0103113","volume":"9","author":"B Spiess","year":"2014","unstructured":"Spiess B, Postina P, Reinwald M, Cornely OA, Hamprecht A, Hoenigl M et\u00a0al (2014) Incidence of Cyp51 A key mutations in aspergillus fumigatus\u2014a study on primary clinical samples of immunocompromised patients in the period of 1995\u20132013. PLOS ONE 9(7):e103113","journal-title":"PLOS ONE"},{"key":"334_CR67","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s12281-016-0254-5","volume":"10","author":"J Prattes","year":"2016","unstructured":"Prattes J, Heldt S, Eigl S, Hoenigl M (2016) Point of care testing for the diagnosis of fungal infections: are we there yet? Curr Fungal Infect Rep 10:43\u201350","journal-title":"Curr Fungal Infect Rep"},{"issue":"8","key":"334_CR68","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/myc.12343","volume":"58","author":"J Prattes","year":"2015","unstructured":"Prattes J, Lackner M, Eigl S, Reischies F, Raggam RB, Koidl C et al (2015) Diagnostic accuracy of the aspergillus-specific bronchoalveolar lavage lateral-flow assay in haematological malignancy patients. Mycoses 58(8):461\u2013469","journal-title":"Mycoses"},{"issue":"6","key":"334_CR69","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.jinf.2012.10.003","volume":"65","author":"M Hoenigl","year":"2012","unstructured":"Hoenigl M, Koidl C, Duettmann W, Seeber K, Wagner J, Buzina W et al (2012) Bronchoalveolar lavage lateral-flow device test for invasive pulmonary aspergillosis diagnosis in haematological malignancy and solid organ transplant patients. J\u00a0Infect 65(6):588\u2013591","journal-title":"J Infect"},{"key":"334_CR70","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2017.05.014","author":"T Orasch","year":"2017","unstructured":"Orasch T, Prattes J, Faserl K, Eigl S, Duttmann W, Lindner H et\u00a0al (2017) Bronchoalveolar lavage triacetylfusarinine C (TAFC) determination for diagnosis of invasive pulmonary aspergillosis in patients with hematological malignancies. J\u00a0Infect. \n                        https:\/\/doi.org\/10.1016\/j.jinf.2017.05.014","journal-title":"J Infect"},{"issue":"2","key":"334_CR71","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s12281-017-0275-8","volume":"11","author":"S Heldt","year":"2017","unstructured":"Heldt S, Hoenigl M (2017) Lateral flow assays for the diagnosis of invasive aspergillosis: current status. Curr Fungal Infect Rep 11(2):45\u201351","journal-title":"Curr Fungal Infect Rep"},{"issue":"5","key":"334_CR72","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1093\/mmy\/myu023","volume":"52","author":"F Pruller","year":"2014","unstructured":"Pruller F, Wagner J, Raggam RB, Hoenigl M, Kessler HH, Truschnig-Wilders M et al (2014) Automation of serum (1\u21923)-beta-D-glucan testing allows reliable and rapid discrimination of patients with and without candidemia. Med Mycol 52(5):455\u2013461","journal-title":"Med Mycol"},{"issue":"11","key":"334_CR73","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1111\/myc.12221","volume":"57","author":"J Prattes","year":"2014","unstructured":"Prattes J, Hoenigl M, Rabensteiner J, Raggam RB, Prueller F, Zollner-Schwetz I et al (2014) Serum 1,3-beta-d-glucan for antifungal treatment stratification at the intensive care unit and the influence of surgery. Mycoses 57(11):679\u2013686","journal-title":"Mycoses"},{"issue":"3","key":"334_CR74","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1128\/JCM.02972-15","volume":"54","author":"J Prattes","year":"2016","unstructured":"Prattes J, Raggam RB, Vanstraelen K, Rabensteiner J, Hoegenauer C, Krause R et al (2016) Chemotherapy-induced intestinal mucosal barrier damage: a\u00a0cause of falsely elevated serum 1,3-beta-d-glucan levels? J\u00a0Clin Microbiol 54(3):798\u2013801","journal-title":"J Clin Microbiol"},{"key":"334_CR75","doi-asserted-by":"crossref","first-page":"404","DOI":"10.3389\/fimmu.2016.00404","volume":"7","author":"M Hoenigl","year":"2016","unstructured":"Hoenigl M, Perez-Santiago J, Nakazawa M, de Oliveira MF, Zhang Y, Finkelman MA et al (2016) (1\u21923)-beta-d-glucan: a biomarker for microbial translocation in individuals with acute or early HIV infection? Front Immunol 7:404","journal-title":"Front Immunol"},{"issue":"1","key":"334_CR76","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.cmi.2015.09.009","volume":"22","author":"J Springer","year":"2016","unstructured":"Springer J, Lackner M, Nachbaur D, Girschikofsky M, Risslegger B, Mutschlechner W et al (2016) Prospective multicentre PCR-based aspergillus DNA screening in high-risk patients with and without primary antifungal mould prophylaxis. Clin Microbiol Infect 22(1):80\u201386","journal-title":"Clin Microbiol Infect"},{"issue":"7","key":"334_CR77","doi-asserted-by":"crossref","first-page":"e101","DOI":"10.1086\/521245","volume":"45","author":"C Lass-Florl","year":"2007","unstructured":"Lass-Florl C, Resch G, Nachbaur D, Mayr A, Gastl G, Auberger J et al (2007) The value of computed tomography-guided percutaneous lung biopsy for diagnosis of invasive fungal infection in immunocompromised patients. Clin Infect Dis 45(7):e101\u2013e104","journal-title":"Clin Infect Dis"},{"issue":"5","key":"334_CR78","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1111\/j.1440-1843.2009.01548.x","volume":"14","author":"Y Kitasato","year":"2009","unstructured":"Kitasato Y, Tao Y, Hoshino T, Tachibana K, Inoshima N, Yoshida M et al (2009) Comparison of aspergillus galactomannan antigen testing with a\u00a0new cut-off index and Aspergillus precipitating antibody testing for the diagnosis of chronic pulmonary aspergillosis. Respirology 14(5):701\u2013708","journal-title":"Respirology"},{"issue":"7","key":"334_CR79","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/j.rmed.2013.04.007","volume":"107","author":"Y Kono","year":"2013","unstructured":"Kono Y, Tsushima K, Yamaguchi K, Kurita N, Soeda S, Fujiwara A et\u00a0al (2013) The utility of galactomannan antigen in the bronchial washing and serum for diagnosing pulmonary aspergillosis. Respir Med 107(7):1094\u20131100","journal-title":"Respir Med"},{"issue":"3","key":"334_CR80","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s15010-014-0711-4","volume":"43","author":"G Cucchetto","year":"2015","unstructured":"Cucchetto G, Cazzadori A, Conti M, Cascio GL, Braggio P, Concia E (2015) Treatment of chronic pulmonary aspergillosis with voriconazole: review of a\u00a0case series. Infection 43(3):277\u2013286","journal-title":"Infection"},{"issue":"12","key":"334_CR81","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1086\/657307","volume":"51","author":"S Kohno","year":"2010","unstructured":"Kohno S, Izumikawa K (2010) Posaconazole for chronic pulmonary aspergillosis: the next strategy against the threat of azole-resistant Aspergillus infection. Clin Infect Dis 51(12):1392\u20131394","journal-title":"Clin Infect Dis"},{"issue":"3","key":"334_CR82","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1080\/13693780701278386","volume":"45","author":"K Izumikawa","year":"2007","unstructured":"Izumikawa K, Ohtsu Y, Kawabata M, Takaya H, Miyamoto A, Sakamoto S et\u00a0al (2007) Clinical efficacy of micafungin for chronic pulmonary aspergillosis. Med Mycol 45(3):273\u2013278","journal-title":"Med Mycol"},{"issue":"7","key":"334_CR83","first-page":"688","volume":"49","author":"S Kohno","year":"2011","unstructured":"Kohno S, Izumikawa K, Kakeya H, Miyazaki Y, Ogawa K, Amitani R et\u00a0al (2011) Clinical efficacy and safety of micafungin in Japanese patients with chronic pulmonary aspergillosis: a\u00a0prospective observational study. Med Mycol 49(7):688\u2013693","journal-title":"Med Mycol"},{"issue":"3","key":"334_CR84","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1136\/thoraxjnl-2013-203988","volume":"69","author":"GJ Keir","year":"2014","unstructured":"Keir GJ, Garfield B, Hansell DM, Loebinger MR, Wilson R, Renzoni EA et\u00a0al (2014) Cyclical caspofungin for chronic pulmonary aspergillosis in sarcoidosis. Thorax 69(3):287\u2013288","journal-title":"Thorax"},{"issue":"5","key":"334_CR85","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.jinf.2016.06.001","volume":"73","author":"PJ Newton","year":"2016","unstructured":"Newton PJ, Harris C, Morris J, Denning DW (2016) Impact of liposomal amphotericin B therapy on chronic pulmonary aspergillosis. J\u00a0Infect 73(5):485\u2013495","journal-title":"J Infect"}],"container-title":["Der Internist"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00108-017-0334-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-017-0334-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-017-0334-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,10,25]],"date-time":"2017-10-25T14:57:52Z","timestamp":1508943472000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00108-017-0334-9"}},"subtitle":["Ignorieren oder behandeln?"],"short-title":[],"issued":{"date-parts":[[2017,10,6]]},"references-count":85,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["334"],"URL":"https:\/\/doi.org\/10.1007\/s00108-017-0334-9","relation":{},"ISSN":["0020-9554","1432-1289"],"issn-type":[{"value":"0020-9554","type":"print"},{"value":"1432-1289","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,6]]}}}